Integra Lifesciences's total assets for Q2 2026 were $3.59B, an increase of 0.23% from the previous quarter. DE:IL3 total liabilities were $2.54B for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.